- Home
- PIII vs NAII Comparison
PIII vs NAII Comparison
Compare PIII & NAII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PIII
- NAII
- Stock Information
- Founded
- PIII 2015
- NAII 1980
- Country
- PIII United States
- NAII United States
- Employees
- PIII N/A
- NAII N/A
- Industry
- PIII Medical/Nursing Services
- NAII Medicinal Chemicals and Botanical Products
- Sector
- PIII Health Care
- NAII Health Care
- Exchange
- PIII Nasdaq
- NAII Nasdaq
- Market Cap
- PIII 20.8M
- NAII 21.2M
- IPO Year
- PIII N/A
- NAII 1987
- Fundamental
- Price
- PIII $6.78
- NAII $3.84
- Analyst Decision
- PIII Buy
- NAII
- Analyst Count
- PIII 2
- NAII 0
- Target Price
- PIII $16.25
- NAII N/A
- AVG Volume (30 Days)
- PIII 12.0K
- NAII 3.3K
- Earning Date
- PIII 08-14-2025
- NAII 09-26-2025
- Dividend Yield
- PIII N/A
- NAII N/A
- EPS Growth
- PIII N/A
- NAII N/A
- EPS
- PIII N/A
- NAII N/A
- Revenue
- PIII $1,461,823,000.00
- NAII $125,483,000.00
- Revenue This Year
- PIII N/A
- NAII N/A
- Revenue Next Year
- PIII $7.92
- NAII N/A
- P/E Ratio
- PIII N/A
- NAII N/A
- Revenue Growth
- PIII 4.20
- NAII 4.39
- 52 Week Low
- PIII $5.80
- NAII $2.57
- 52 Week High
- PIII $30.50
- NAII $6.88
- Technical
- Relative Strength Index (RSI)
- PIII 48.91
- NAII 66.23
- Support Level
- PIII $6.42
- NAII $3.62
- Resistance Level
- PIII $7.11
- NAII $3.90
- Average True Range (ATR)
- PIII 0.55
- NAII 0.11
- MACD
- PIII -0.03
- NAII 0.01
- Stochastic Oscillator
- PIII 45.35
- NAII 79.31
About PIII P3 Health Partners Inc.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.
About NAII Natural Alternatives International Inc.
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.